Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether HealthEquity and certain of its officers and/or ...

Such investors are advised to contact Danielle Peyton at ... or 646-581-9980, ext. 7980. The investigation concerns whether HealthEquity and certain of its officers and/or directors have engaged ...

Investors and stakeholders in HealthEquity will be watching closely ... by $17 million in additional service costs related to fraud issues, which have been a significant challenge for the company.

Baron Health Care Fund retreated in the first quarter of 2025, underperforming its benchmark, the Russell 3000 Health Care ...

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications ...

Revelation Biosciences, Inc. (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced a new target indication ...

Investors and stakeholders in HealthEquity will be watching closely to see how these ... The earnings were impacted by $17 million in additional service costs related to fraud issues, which have been ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from ...

On this news, HealthEquity's shares fell 17% on March 19, 2025. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often ...

New York, New York--(Newsfile Corp. - April 26, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of ...